{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:17:20Z","timestamp":1760015840729},"reference-count":141,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.pnpbp.2004.05.024","type":"journal-article","created":{"date-parts":[[2004,8,5]],"date-time":"2004-08-05T15:25:56Z","timestamp":1091719556000},"page":"801-811","source":"Crossref","is-referenced-by-count":19,"title":["N-methyl-d-aspartate antagonists as drug models of schizophrenia: a surprising link to tobacco smoking"],"prefix":"10.1016","volume":"28","author":[{"given":"Edward F.","family":"Domino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Mirzoyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2004.05.024_BIB1","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1523\/JNEUROSCI.22-09-03708.2002","article-title":"Prefrontal dopamine D1 receptors and working memory in schizophrenia","volume":"22","author":"Abi-Dargham","year":"2002","journal-title":"J. Neurosci"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB2","first-page":"3","article-title":"PET imaging of prefrontal dopamine D1 receptors in chronic PCP\/ketamine human abusers: a model for schizophrenia","author":"Abi-Dargham","year":"2003","journal-title":"Sci. Abstr., Am. Coll. Neuropsychopharmacol"},{"issue":"suppl.","key":"10.1016\/j.pnpbp.2004.05.024_BIB3","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1055\/s-2007-979354","article-title":"The NMDA antagonist model for schizophrenia: promise and pitfalls","volume":"31","author":"Abi-Saab","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB4","series-title":"Neuropsychopharmacology: The Fifth Generation of Progress","first-page":"1545","article-title":"Psychedelic drugs","author":"Abraham","year":"2002"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB5","first-page":"639","article-title":"Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia","volume":"17","author":"Adler","year":"1982","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0006-3223(92)90073-9","article-title":"Normalization of deficient auditory sensory gating in the relatives of schizophrenics by nicotine","volume":"32","author":"Adler","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB7","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1176\/ajp.150.12.1856","article-title":"Normalization of auditory physiology by cigarette smoking in schizophrenic patients","volume":"150","author":"Adler","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB8","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/oxfordjournals.schbul.a033320","article-title":"Schizophrenia, sensory gating, and nicotine receptors","volume":"24","author":"Adler","year":"1998","journal-title":"Schizophr. Bull"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB9","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1176\/ajp.135.9.1081","article-title":"Phencyclidine-induced psychosis","volume":"135","author":"Allen","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/schbul\/13.1.9","article-title":"The diagnosis of schizophrenia","volume":"13","author":"Andreasen","year":"1987","journal-title":"Schizophr. Bull"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB11","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/S0140-6736(96)08258-X","article-title":"Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-na\u0131\u0308ve patients","volume":"349","author":"Andreasen","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0166-2236(84)80062-4","article-title":"CNS stimulants as a tool in the study of schizophrenia","volume":"7","author":"Angrist","year":"1984","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0014-2999(82)90158-3","article-title":"The effects of nicotine administration on 5-HT uptake and biosynthesis in rat brain","volume":"84","author":"Benwell","year":"1982","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB14","series-title":"Neurobiology of Mental Illness","first-page":"311","article-title":"Chap. 23. Functional brain imaging studies in schizophrenia","author":"Berman","year":"2004"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1192\/bjp.150.2.154","article-title":"Changes in auditory P3 event-related potential in schizophrenia and depression","volume":"150","author":"Blackwood","year":"1987","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/schbul\/19.2.233","article-title":"Information processing and attention dysfunctions in schizophrenia","volume":"19","author":"Braff","year":"1993","journal-title":"Schizophr. Bull"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB17","series-title":"Neurobiology of Mental Illness","first-page":"324","article-title":"Chap. 24. Psychophysiological and information processing approaches to schizophrenia","author":"Braff","year":"2004"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB18","series-title":"Neuropsychopharmacology. The Fifth Generation of Progress","first-page":"703","article-title":"Chap. 51. Endophenotypes in studies of the genetics of schizophrenia","author":"Braff","year":"2002"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB19","first-page":"7","article-title":"Effect of smoking history on (3H)nicotine binding in human postmortem brain","volume":"282","author":"Breese","year":"1997","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0893-133X(00)00121-4","article-title":"Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia","volume":"23","author":"Breese","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB21","series-title":"Neurobiology of Mental Illness","first-page":"237","article-title":"Chap. 18. Diagnostic classification of the psychoses: historical context and implications for neurobiology","author":"Breir","year":"2004"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1192\/bjp.177.3.212","article-title":"Causes of excess mortality of schizophrenia","volume":"177","author":"Brown","year":"2000","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB23","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1176\/appi.ajp.157.10.1660","article-title":"Modulation of the startle response and startle laterality in relatives of schizophrenic patients and schizotypal disordered subjects: evidence of inhibitory deficits","volume":"157","author":"Cadenhead","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"396.12","key":"10.1016\/j.pnpbp.2004.05.024_BIB24","first-page":"1058","article-title":"Heterozygous reeler mice (rl+\/\u2212) display increased cognitive impairment when treated with dizolcipine","volume":"26","author":"Carboni","year":"2000","journal-title":"Soc. Neurosci. Abs"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1017\/S003329170000622X","article-title":"Does dopamine play a role in schizophrenia?","volume":"7","author":"Carlsson","year":"1977","journal-title":"Psychol. Med"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0893-133X(88)90012-7","article-title":"The current status of the dopamine hypothesis of schizophrenia","volume":"1","author":"Carlsson","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0893-133X(88)90017-6","article-title":"Reply to commentaries on \u201cThe current status of the dopamine hypothesis of schizophrenia\u201d","volume":"1","author":"Carlsson","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB28","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1093\/nar\/gkf401","article-title":"On the epigenetic regulation of the human reelin promoter","volume":"30","author":"Chen","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB29","series-title":"Neurobiology of Mental Illness","first-page":"299","article-title":"Chap. 22. The neurobiology of schizophrenia","author":"Choy","year":"2004"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB30","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archpsyc.1959.03590060113013","article-title":"Comparison of Sernyl with other drugs: I. Attention, motor function, and proprioception","volume":"1","author":"Cohen","year":"1959","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0010-440X(60)80057-0","article-title":"Combined Sernyl and sensory deprivation","volume":"1","author":"Cohen","year":"1960","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/archpsyc.1962.01710230063007","article-title":"Comparison of phencyclidine hydrochloride (Sernyl) with other drugs: II. Symbolic and sequential thinking","volume":"6","author":"Cohen","year":"1962","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB33","first-page":"209","article-title":"The administration of methionine to chronic schizophrenic patients: a review of ten studies","volume":"8","author":"Cohen","year":"1974","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB34","first-page":"125","article-title":"Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion","volume":"271","author":"Collins","year":"1994","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB35","first-page":"723","article-title":"Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability","volume":"8","author":"Costa","year":"2001","journal-title":"Neurobiology"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/mi.2.1.47","article-title":"Reelin and schizophrenia: a disease at the interface of the genome and epigenome","volume":"2","author":"Costa","year":"2002","journal-title":"Mol. Interv"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1471-4892(01)00121-7","article-title":"The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics","volume":"1","author":"Costa","year":"2002","journal-title":"Curr. Opin. Pharmacol"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB38","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-003-1709-2","article-title":"The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia","author":"Coyle","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"19","author":"Creese","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB40","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1176\/ajp.155.11.1490","article-title":"Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings","volume":"1555","author":"Dalack","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB41","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1192\/bjp.106.444.912","article-title":"The effect of 1-arylcyclohexylamine (Sernyl) on twelve normal volunteers","volume":"106","author":"Davies","year":"1960","journal-title":"J. Ment. Sci"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB42","first-page":"185","article-title":"Indoleakylamines as psychotogen precursors\u2014possible neurotransmitter imbalance","author":"Domino","year":"1975"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB43","series-title":"Predictability in Psychopharmacology: Preclinical and Clinical Correlations","first-page":"247","article-title":"The indole hallucinogen model: is it worth pursuing?","author":"Domino","year":"1975"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB44","series-title":"Animal Models in Human Psychobiology","first-page":"239","article-title":"Indole hallucinogens as animal models of schizophrenia","author":"Domino","year":"1976"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB45","series-title":"PCP (Phencyclidine): Historical and Current Perspectives","first-page":"1","year":"1981"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0006-3223(96)82519-4","article-title":"Monoamine oxidase, tobacco smoking and psychiatric disorders","volume":"40","author":"Domino","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB47","first-page":"181","article-title":"Conflicting evidence for the dopamine release theory of nicotine\/tobacco dependence","volume":"22","author":"Domino","year":"2002","journal-title":"Nihon Shinkei (Jpn. J. Neuropsychopharmacol.)"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB48","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1176\/ajp.134.11.1280","article-title":"In vitro half life of 14C-tryptamine in whole blood of mentally normal controls and drug-free chronic schizophrenic patients","volume":"134","author":"Domino","year":"1977","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1176\/ajp.133.3.323","article-title":"Decreased blood platelet MAO activity in unmedicated chronic schizophrenic patients","volume":"133","author":"Domino","year":"1976","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/14622200110098400","article-title":"Tobacco smoking increases gating of irrelevant and enhances attention to relevant tones","volume":"4","author":"Domino","year":"2002","journal-title":"Nicotine Tob. Res"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB51","series-title":"PCP (Phencyclidine): Historical and Current Perspectives","first-page":"401","article-title":"Abnormal mental states induced by phencyclidine as a model of schizophrenia","author":"Domino","year":"1981"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB52","first-page":"431","article-title":"Chap. 7. Neuropathology of psychiatric disorders","volume":"vol. 2","author":"Esiri","year":"2002"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB53","first-page":"183","article-title":"The psychiatric aspects of chronic phencyclidine use: a study of chronic PCP users","volume":"21","author":"Fauman","year":"1978","journal-title":"NIDA Res. Monogr"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB54","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00005053-195609000-00006","article-title":"Symposium on atropine toxicity therapy","volume":"124","author":"Forrer","year":"1956","journal-title":"J. Nerv. Ment. Dis"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB55","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/379733a0","article-title":"Inhibition of monoamine oxidase B in the brains of smokers","volume":"379","author":"Fowler","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB56","doi-asserted-by":"crossref","first-page":"14059","DOI":"10.1073\/pnas.93.24.14065","article-title":"Brain monoamine oxidase A inhibition in cigarette smokers","volume":"93","author":"Fowler","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB57","series-title":"Neuropsychology, Psychophysiology, and Information Processing","first-page":"71","article-title":"Event-related potentials: exogenous components","volume":"vol. 5","author":"Freedman","year":"1991"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB58","first-page":"537","article-title":"Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients","volume":"18","author":"Freedman","year":"1983","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB59","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/schbul\/13.4.669","article-title":"Neurobiological studies of sensory gating in schizophrenia","volume":"13","author":"Freedman","year":"1987","journal-title":"Schizophr. Bull"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB60","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1073\/pnas.94.2.587","article-title":"Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus","volume":"94","author":"Freedman","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0893-133X(88)90014-0","article-title":"Dopamine as a mediator of a central stabilizing system","volume":"1","author":"Friedhoff","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB62","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/jnnp.65.4.446","article-title":"Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia","volume":"65","author":"Garey","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archpsyc.57.1.65","article-title":"Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia","volume":"57","author":"Glantz","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB64","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1176\/ajp.150.4.546","article-title":"Cigarette smoking: implications for psychiatric illness","volume":"150","author":"Glassman","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB65","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1176\/appi.ajp.158.9.1367","article-title":"The emerging role of glutamate in the pathophysiology and treatment of schizophrenia","volume":"158","author":"Goff","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB66","first-page":"1180","article-title":"Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects","volume":"149","author":"Goff","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB67","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1176\/jnp.6.4.348","article-title":"Working memory dysfunction in schizophrenia","volume":"6","author":"Goldman-Rakic","year":"1994","journal-title":"J. Neuropsychiatry Clin. Neurosci"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB68","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archpsyc.57.11.1061","article-title":"Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study","volume":"57","author":"Guidotti","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB69","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1023\/A:1007635927069","article-title":"New neurochemical markers for psychosis: a working hypothesis of their operation","volume":"25","author":"Guidotti","year":"2000","journal-title":"Neurochem. Res"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB70","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/brain\/122.4.593","article-title":"The neuropathology of schizophrenia: a critical review of the data and their interpretation","volume":"122","author":"Harrison","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB71","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.181.4095.179","article-title":"Eye-tracking patterns in schizophrenia","volume":"181","author":"Holzman","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB72","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.95.26.15718","article-title":"A decrease of reelin expression as a putative vulnerability factor in schizophrenia","volume":"95","author":"Impagnatiello","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB73","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF01825649","article-title":"Encephalograhische sutdien an chronish schizophrenen","volume":"81","author":"Jacobi","year":"1927","journal-title":"Arch. Psychiatr. Nervenkr"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB74","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB75","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB76","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(76)90890-4","article-title":"Cerebral ventricular size and cognitive impairment in chronic schizophrenia","volume":"2","author":"Johnstone","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB77","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB78","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0022-3956(87)90089-6","article-title":"The significance of genetic factors in the etiology of schizophrenia: results from the national study of adoptees in Denmark","volume":"21","author":"Kety","year":"1987","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB79","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0022-3956(68)90026-5","article-title":"The types and prevalence of mental illness in the biological and adoptive families of adopted schizophrenics","volume":"6","author":"Kety","year":"1968","journal-title":"J. Psychiatr. Res"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB80","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archpsyc.1994.03950060006001","article-title":"Mental illness in the biological and adoptive relatives of schizophrenic adoptees: replication of the Copenhagen study in the rest of Denmark","volume":"51","author":"Kety","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB81","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0893-133X(88)90013-9","article-title":"Rheostat and cybernetic issues","volume":"1","author":"Klein","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB82","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB83","series-title":"Neurobiology of Mental Illness","first-page":"287","article-title":"Chap. 21. Pharmacological models of psychoses","author":"Krystal","year":"2004"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB84","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-002-1099-x","article-title":"Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research","volume":"162","author":"Kumari","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB85","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/026988119901300405","article-title":"Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies","volume":"13","author":"Laruelle","year":"1999","journal-title":"J. Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB86","series-title":"Positron Emission Tomography: Basic Science and Clinical Practice","first-page":"399","article-title":"Molecular imaging in psychiatric disorders","author":"Laruelle","year":"2002"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB87","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/schbul\/22.3.431","article-title":"Nicotinic receptor function in schizophrenia","volume":"22","author":"Leonard","year":"1996","journal-title":"Schizophr. Bull"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB88","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0091-3057(01)00677-3","article-title":"Smoking and mental illness","volume":"70","author":"Leonard","year":"2001","journal-title":"Pharmacol., Biochem. Behav"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB89","series-title":"Electrophysiological Studies of the Interaction Between Phencyclidine\/Sigma Receptor Agonists and Excitatory Amino Acid Neurotransmission on Central Mammalian Neurons","first-page":"239","author":"Lodge","year":"1988"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB90","series-title":"PCP (Phencyclidine): Historical and Current Perspectives","first-page":"25","article-title":"Chap. 4. Phencyclidine revisited","author":"Luby","year":"1981"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB91","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/archneurpsyc.1959.02340150095011","article-title":"Study of a new schizophrenomimetic drug\u2014Sernyl","volume":"81","author":"Luby","year":"1959","journal-title":"Arch. Neurol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB92","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1176\/ajp.119.1.61","article-title":"Model psychoses and schizophrenia","volume":"119","author":"Luby","year":"1962","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB93","first-page":"241","article-title":"The phencyclidine psychosis: phenomenology and treatment","volume":"21","author":"Luisada","year":"1978","journal-title":"NIDA Res. Monogr"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB94","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0893-133X(95)00137-3","article-title":"NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers","volume":"14","author":"Malhotra","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB95","first-page":"817","article-title":"Effects of chronic nicotine infusion on tolerance development and nicotinic receptors","volume":"226","author":"Marks","year":"1983","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB96","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.145.4.429","article-title":"Smoking and malignancy in schizophrenia","volume":"145","author":"Matherson","year":"1984","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB97","first-page":"200","article-title":"Antipsychotic drug actions: a clue to the neuropathology of schizophrenia","volume":"32","author":"Matthysse","year":"1973","journal-title":"Fed. Proc"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB98","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0006-3223(99)00018-9","article-title":"MRI anatomy of schizophrenia","volume":"45","author":"McCarley","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB99","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-0173(90)90011-C","article-title":"Physiological and pathophysiological roles of excitatory amino acids during central nervous system development","volume":"15","author":"McDonald","year":"1990","journal-title":"Brain Res. Rev"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0893-133X(88)90015-2","article-title":"New insights into schizophrenia through atypical antipsychotic drugs","volume":"1","author":"Meltzer","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB101","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/BF00449814","article-title":"Clozapine: new research on efficacy and mechanism of action","volume":"238","author":"Meltzer","year":"1989","journal-title":"Eur. Arch. Psychiatr. Neurol. Sci"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB102","first-page":"238","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values","volume":"251","author":"Meltzer","year":"1989","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB103","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0896-6273(00)00085-4","article-title":"Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex","volume":"28","author":"Mirnics","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB104","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0028-3908(68)90067-1","article-title":"Neuronal mechanisms of ketamine-induced anesthesia","volume":"7","author":"Miyasaka","year":"1968","journal-title":"Int. J. Neuropharmacol"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.npp.1300342","article-title":"Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers","volume":"29","author":"Morgan","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB106","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(98)00067-0","article-title":"Ketamine-induced NMDA receptor hypofunction as model of memory impairment and psychosis","volume":"20","author":"Newcomer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB107","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/385634a0","article-title":"Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET","volume":"386","author":"Okubo","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB108","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB109","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.npp.1380292","article-title":"NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia","volume":"13","author":"Olney","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB110","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0006-3223(99)00071-2","article-title":"Structural brain imaging in schizophrenia: a selective review","volume":"46","author":"Pearlson","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB111","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00005072-199907000-00001","article-title":"The neuropathology of schizophrenia","volume":"58","author":"Powers","year":"1999","journal-title":"J. Neuropath. Exp. Neurol"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB112","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0891-0618(01)00113-2","article-title":"GABAergic neuronal subtypes in the human frontal cortex-development and deficits in schizophrenia","volume":"22","author":"Reynolds","year":"2001","journal-title":"J. Chem. Neuroanat"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB113","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0361-9230(01)00526-3","article-title":"Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective loses of calcium binding protein immunoreactivity","volume":"55","author":"Reynolds","year":"2001","journal-title":"Brain Res. Bull"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB114","series-title":"Neurobiology of Mental Illness","first-page":"247","article-title":"Chap. 19. Molecular genetics of schizophrenia","author":"Riley","year":"2004"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB115","series-title":"Neurobiology of Mental Illness","first-page":"263","article-title":"Chap. 20. Animal models of the psychoses","author":"Robbins","year":"2004"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB116","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/0013-4694(59)90122-1","article-title":"Electroencephalographic findings associated with Sernyl infusion","volume":"11","author":"Rodin","year":"1959","journal-title":"EEG Clin. Neurophysiol"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB117","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1073\/pnas.050589797","article-title":"Colocalization of integrin receptors and reelin in dendritic spine postsynaptic densities of adult nonhuman primate cortex","volume":"97","author":"Rodriguez","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB118","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00002826-199408000-00008","article-title":"Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: a retrospective study","volume":"17","author":"Rosse","year":"1994","journal-title":"Clin. Neuropharm"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB119","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1176\/ajp.128.3.336","article-title":"Auditory evoked response, EEG, and thought process in schizophrenics","volume":"128","author":"Saletu","year":"1971","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB120","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1126\/science.1070532","article-title":"Schizophrenia: diverse approaches to a complex disease","volume":"296","author":"Sawa","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB121","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1126\/science.1825731","article-title":"D1 dopamine receptors in prefrontal cortex: involvement in working memory","volume":"251","author":"Sawaguchi","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB122","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/jn.1994.71.2.515","article-title":"The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task","volume":"71","author":"Sawaguchi","year":"1994","journal-title":"J. Neurophysiol"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB123","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1126\/science.6828889","article-title":"Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo","volume":"220","author":"Schwartz","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB124","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.1145194","article-title":"Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons","volume":"188","author":"Seeman","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB125","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/261717a0","article-title":"Antipsychotic drug doses and neuroleptic\/dopamine receptors","volume":"261","author":"Seeman","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0006-3223(98)00281-9","article-title":"The reduced neuropil hypothesis: a circuit-based model of schizophrenia","volume":"45","author":"Selemon","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00163-3","article-title":"A review of MRI findings in schizophrenia","volume":"49","author":"Shenton","year":"2001","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB128","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1176\/ajp.130.1.61","article-title":"Amphetamine psychosis: a \u2018model\u2019 schizophrenia mediated by catecholamines","volume":"130","author":"Snyder","year":"1973","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0893-133X(88)90016-4","article-title":"Psychotropic drugs as models of schizophrenia","volume":"1","author":"Snyder","year":"1988","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/archneur.1976.00500030056012","article-title":"Electroencephalographic findings in phencyclidine intoxication","volume":"33","author":"Stockard","year":"1976","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB131","series-title":"Neurobiology of Mental Illness","first-page":"339","article-title":"Chap. 25. Principles of the pharmacotherapy of schizophrenia","author":"Taminga","year":"2004"},{"issue":"suppl. 37","key":"10.1016\/j.pnpbp.2004.05.024_BIB132","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1192\/S0007125000293586","article-title":"Cholinergic aspects of schizophrenia","volume":"174","author":"Tandon","year":"1999","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB133","doi-asserted-by":"crossref","first-page":"17095","DOI":"10.1073\/pnas.262658999","article-title":"An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability","volume":"99","author":"Tremolizzo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB134","first-page":"3","article-title":"NMDA antagonisms impairs dopamine system in prefrontal cortex: PET study with conscious monkeys","author":"Tsukada","year":"2003","journal-title":"Sci. Abstr., Am. Coll. Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/syn.10102","article-title":"Comparative effects of methamphetamine and nicotine on the striatal [11C]raclopride binding in unanesthetized monkeys","volume":"45","author":"Tsukada","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB136","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archpsyc.1987.01800190080012","article-title":"Implications of normal brain development for the pathogenesis of schizophrenia","volume":"44","author":"Weinberger","year":"1987","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB137","series-title":"Neurobiology of Mental Illness","first-page":"233","article-title":"Editor, Section III. Psychoses","author":"Weinberger","year":"2004"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB138","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archpsyc.1979.01780070013001","article-title":"Lateral cerebral ventricular enlargement in chronic schizophrenia","volume":"36","author":"Weinberger","year":"1979","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB139","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archpsyc.1986.01800020020004","article-title":"Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: I. regional cerebral blood flow (rCBF) evidence","volume":"43","author":"Weinberger","year":"1986","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0165-6147(90)90242-Z","article-title":"The paradox of nicotinic acetylcholine receptor upregulation by nicotine","volume":"11","author":"Wonnacott","year":"1990","journal-title":"Trends Pharmacol. Sci"},{"key":"10.1016\/j.pnpbp.2004.05.024_BIB141","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1176\/ajp.157.1.16","article-title":"Meta-analysis of regional brain volumes in schizophrenia","volume":"157","author":"Wright","year":"2000","journal-title":"Am. J. Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584604000818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584604000818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T23:02:00Z","timestamp":1585868520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584604000818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":141,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0278584604000818"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2004.05.024","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}